The pharmacological landscape and therapeutic potential of serine hydrolases
By D. Bachovchin, B. Cravatt. 2012
284 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Organic Chemistry
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity (2023, background): “Covalent inhibitors that react with the serine hydrolase family have long been an important designed modality in the identification of structural and chemical biology tools, and new therapeutics [18,19].”